Scientists sequence genome of Asian liver fluke, a cancer-causing parasite

NewsGuard 100/100 Score

Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini.  This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.

The study has been published online in the journal Nature Communications.

Lead investigators, Dr Neil Young and Professor Robin Gasser, from the University of Melbourne, worked with an international team of experts, including Dr Niranjan Nagarajan and Patrick Tan from the Genome Institute of Singapore, to assemble and characterise the largest parasitic worm genome studied to date.

Dr Young said, “This study provides insight into how the fluke survives the hostile environment within the human bile duct, and provides further evidence that these parasites release proteins that directly alter human tissue.”

The parasite is carried by snails and fish and infects humans, cats and dogs through the eating of raw fish. It migrates to the liver and bile duct causing a range of chronic liver and gall bladder diseases including cancers.

Prof Gasser said, “Work on the fluke is crucial to understand how the parasite lives in the bile ducts of the liver. Currently, there is no vaccine and only one drug available to treat infection.

“Our new genome resource will underpin profound explorations of cancer-causing parasites, and could lead to new treatments against parasites and parasite-induced cancers.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show